Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsTimothy P. Hughes, Anthony P. Schwarer, Susan Branford et al.|Leukemia|2018Cited by 78
Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cellsYazad Irani, Agnes S. M. Yong, Amy Hughes et al.|British Journal of Haematology|2020Cited by 77
High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatmentSusan L. Heatley, Deborah L. White, Teresa Sadras et al.|Haematologica|2017Cited by 62
Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionIlaria S. Pagani, David M. Ross, Phuong Dang et al.|Leukemia|2019Cited by 51
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapyEva Nievergall, Deborah L. White, John Reynolds et al.|Leukemia|2016Cited by 50